Conspiracy theories abound when vaccine manufacturers get away with secret EU deals.

Biohaven has failed its trial program with a treatment for Alzheimer's disease in phase II-III, but hopes follow-up analyses will have promising outcome, so the firm will not have to ditch the drug.

Tuesday EMA informed that December attack files have been leaked. The specific nature of the documents is unknown but the involved parties may have cause for concern.

Hearing aid company WS Audiology is the first established industry player to present a hearing aid designed as the type of earbuds which for example Apple has been hugely successful with. The goal is to attract younger customers to the shop, according to the firm, which calls the new product an "actual paradigm shift".

Due to higher discount levels than expected, the EU migraine market may soon be worth as much as the US market, according to Teva CEO Kåre Schultz.

Eli Lilly has sent supplemental new drug application to US FDA for use of diabetes drug Jardiance.